CONVATEC GROUP PLC

Convatec surges 1.95% in a bullish market, driven by steady demand for essential medical supplies, global reach, and solid cash flow – a clear edge for risk‑averse investors.

Convatec shares rise 1.95% on a solid healthcare trend, backed by strong liquidity, robust market cap, and growth in R&D‑driven medical devices.

Convatec shares slip 0.08%, riding a FTSE 100 wave but lacking real catalyst; investors should watch for breakthrough innovation to unlock true upside.